Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...

E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS; SETS FULL YEAR 2025 OUTLOOK Indianapolis, IN - January 23, 2025 - Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond healthcare, we deliver value to the members and care providers we serve by ensuring simple, affordable, and accessible care. Our fourth quarter results demonstrate tangible progress ...

Elevance Health, Inc. (ELV) is set to report fourth-quarter 2024 results on Jan. 23, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $3.82 per share on revenues of $44.67 billion. See the Zacks Earnings Calendar to stay ahead of market-making news.The fourth-quarter earnings estimate remained stable over the past 30 days. However, the bottom-line projection indicates a year-over-year decline of 32%. The Zacks Consensus Estimate for ...

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%. It is anticipated that revenues will amount to $44.67 billion, exhibiting an increase of 5.2% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial ...

Company Overview - Elevance Health (NYSE: ELV) is a major health insurance provider in the United States, serving approximately 47 million members [1] - The company appears to be in strong financial condition [1] Stock Performance - Elevance Health's stock has significantly outperformed the overall market [1] Author Background - The author holds a Ph.D. in engineering and has expertise in acoustics and noise research [2] - The author is passionate about finance and stock investment, with a focus on capital appreciation opportunities [2] - The author's investment strategy includes purchasing high-quality undervalued companies and reasonably priced growth companies [2] - The author also invests in dividend-paying stocks that are good companies and correctly priced [2] Note: The content does not provide specific financial data, percentage changes, or detailed industry analysis, so those aspects are not included in the summary

U.S. health benefits company Elevance Health, Inc. (ELV) shares have declined 29.6% quarter to date, underperforming its industry and the S&P 500 Index. Closing at $366.48 on Thursday, near its 52-week low of $362.21, the company’s current share price seems an excellent opportunity to build a position in a renowned company. After all, you would much rather buy closer to the low than the high, right?Elevance Health, headquartered in Indianapolis, IN, has a market capitalization of $84.9 billion. Its peers, U ...

SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors violated securities laws and breached fiduciary duties to shareholders. Elevance is a healthcare company that supports consumers, families, and communities across the entire care journey. What Now: If you own shares of Elevance Health Inc. and have lost money in your investment, contact us for more information ab ...

Elevance Health (NYSE: ELV ) is one of the largest healthcare insurers in the US. During FY23, they had 45 million members and had served over 115 million people. They have enjoyed revenue growth of 9.1% over the past 10 years and 13.7% EPSWe use Cash Flow Returns On Investment based DCF valuation tools provided by our affiliate company, ROCGA Research.With over 20 years of experience in investment analysis, we are actively seeking out undervalued and quality companies.ROCGA Research is an online platform t ...

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securities laws by misrepresenting or failing to timely disclose material information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Elevance securities? If you purchased securities and suffered losses on your investmen ...

Elevance Health, Inc. Conference Call Summary Company Overview - **Company**: Elevance Health, Inc. (NYSE: ELV) - **Event**: UBS Global Healthcare Conference - **Date**: November 12, 2024 - **Key Speaker**: Mark Kaye, Executive VP & CFO Key Points Financial Outlook - **2025 EPS Growth**: Expected mid-single-digit growth in adjusted diluted earnings per share [2] - **Revenue Growth**: Anticipated strong acceleration into high single-digit percentage range, driven by commercial business momentum and geographic expansion into three new states [3] - **Medicare Advantage Membership**: Slightly ahead of overall market growth due to stronger retention [3] - **Investment in Technology**: Continued investment in business transformation through new technologies, including generative AI, expected to drive operational efficiencies [4] Medicaid Business Challenges - **Operating Environment**: Challenging conditions expected to persist, with Medicaid margins anticipated to remain below the long-term target range of 2% to 4% due to rate and acuity disconnects [5] - **Rate Increases**: 2024 average annual rate increases are at the highest level in a decade, but reimbursement still lags medical costs [11] - **Cost Trends**: Elevated cost trends in Medicaid membership due to higher acuity, with trends running 3x to 5x higher than normal [14][15] Medicare Advantage Strategy - **Benefit Design**: The company remains comfortable with its Medicare Advantage positioning for 2025, balancing membership and margin growth [27] - **Enrollment Growth**: Expectation for individual Medicare Advantage membership growth slightly above market rates, driven by improved retention [29] - **Margin Expectations**: Anticipated slight margin improvement in 2025, but still below target margin range of 3% to 5% [37] Commercial Business Performance - **Segment Growth**: The Commercial business has performed well, with strong retention and growth in Individual ACA membership [40] - **Cost Trends**: Higher than historical averages, but pricing remains firm and in line with expectations [41] - **Repricing Cycle**: Completion of a two-year repricing cycle expected to return to normal membership growth patterns [44] Carelon Initiatives - **Acquisitions**: Successful integration of Kroger Specialty Pharmacy and other acquisitions aimed at enhancing service offerings [50][51] - **Joint Venture**: Formation of Mosaic Health to enhance primary care delivery and value-based care [54] - **Cross-Selling Strategy**: Strong progress in expanding services to fee-based employers, targeting a shift in contribution ratios [58] Capital Deployment Strategy - **M&A Focus**: Strategic M&A remains a key component of growth, with a target of 50% of free cash flow allocated to M&A or organic reinvestment [68] - **Shareholder Returns**: Approximately 30% of free cash flow expected to be returned to shareholders through share repurchases and dividends [70] Additional Insights - **Market Disruption**: Notable market disruption due to nearly 2 million seniors receiving termination notices, impacting member shopping behavior [31] - **Geographic Variability**: Differences in geographic footprint and member mix can lead to varying cost trends and performance [19][20] - **Long-Term Strategy**: Focus on bending the cost curve down while improving health outcomes and affordability for members [72] This summary encapsulates the key insights and financial outlook discussed during the Elevance Health conference call, highlighting the company's strategic initiatives and market challenges.